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Abstract
Background: Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including
cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor
prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study
is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the
disease progression.
Methods: In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA
and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA
immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging.
Results: We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might
associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially
expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be
stimulated by short-term oxidative stress responses to H2O2 and glucose oxidase in CCA cell lines. Further studies
revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19
and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373,
respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4.
Conclusions: Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and
invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively.
The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study
provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the
development of new countermeasures of CCA.
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Background
CCA is broadly described as malignancies originating
from a malignant transformation of cholangiocytes and
epithelial cells lining the intra-hepatic and extra-hepatic
biliary ducts. CCA is difficult to diagnose and cure,
partly due to the unknown molecular mechanisms
underlying the development of CCA. In the past two
decades, several studies have described molecular details
regarding the malignant transformation of cholangio-
cytes and the environment of chronic inflammation in
bile ducts with subsequent cholangiocyte damage, which
is most commonly believed to contribute to CCA patho-
genesis [1, 2]. A variety of inflammatory cytokines,
including IL-6, IL-8, and TGFβ [2, 3], were found to
contribute to the apoptosis, senescence, migration,
invasion, and cell cycle regulation of malignant cholan-
giocytes [4]. Oxidative stress, potentially caused by
Clonorchis sinensis, Opisthorchis viverrini, hepatitis B
virus (HBV) infection, or inflammation [5–8], is also im-
plicated in CCA development. The increased reactive
oxygen species (ROS) produced by oxidative stress can
damage lipids, proteins, and DNA and subsequently alter
different cellular pathways and influence gene expres-
sion, which may induce tumor promotion and progres-
sion [9]. Persistent oxidative stress might also induce
inflammatory responses, implying a complex association
between oxidative stress and inflammation in CCA [7].
Previous studies have reported that malignant trans-
formation of cholangiocytes was associated with chronic
inflammation in the biliary epithelium; however, detailed
molecular mechanisms of CCA promotion and progres-
sion are still unclear.
Recently, promising evidence has shown that non-
coding RNAs serve as ideal diagnostic biomarkers and
participate in oxidative stress and disease or cancer-
related inflammation [10–14]. Small non-coding RNAs,
especially microRNAs (miRNAs), are widely reported to
play vital roles in disease pathogenesis, including the
pathogenesis of CCA, and their post-transcriptional
regulatory mechanisms [15, 16]. Several miRNAs, such
as miR-370 [17], miR-373 [18, 19], and miR-21 [20, 21],
are dysregulated and play vital roles in CCA. However,
none of these miRNAs have been indicated to regulate
inflammation or oxidative stress.
In addition to miRNAs, a set of long non-coding
RNAs (lncRNAs), that are more than 200 nucleotides in
length, have also been reported to play pivotal roles in a
variety of diseases. Some lncRNAs, including ANRIL
[22], HOTAIR [23], and H19 [24], influence many
processes in various cancers, including chromatin re-
modeling, X chromosomal inactivation, transcriptional
regulation, molecular trafficking [25], inflammation re-
sponses, and oxidative stress [10–12, 14]. These observa-
tions suggest potential pathophysiological contributions
from lncRNAs in CCA and imply that some lncRNAs
might be involved in the inflammation response path-
ways stimulated by infection. Recently, the mechanisms
and functions of several lncRNAs, such as lncRNA-
HEIH [26], HULC [27], and HOTAIR [28], were uncov-
ered in hepatic carcinoma, the most common hepatic
malignancy, and these findings led to the construct of
regulation networks and extended our knowledge re-
garding tumorigenesis in hepatic carcinoma. Similarly,
dysregulated lncRNAs in CCA may play an important
role in CCA promotion and progression through in-
volvement in CCA key pathways, such as inflammation
or oxidative stress. Currently, no lncRNAs have been re-
ported to be associated with CCA progression.
In this study, we sought to determine if any lncRNA is
stimulated by oxidative stress and trigger inflammation
in CCA. We identified a set of lncRNAs that participated
in inflammation and oxidative stress response. Two
dysregulated lncRNAs H19 and HULC were shown to
promote cell migration and invasion through ceRNA
manners leading to the activation of inflammation cyto-
kine IL-6 and chemokine receptor CXCR4. Our findings
may provide potential biomarkers for CCA progression
and potential therapeutic targets for the disease.
Methods
Cell lines
QBC939 human cholangiocarcinoma cells were obtained
from Shuguang Wang (The Third Military Medical
University, China). SK-cha-1 human cholangiocarcinoma
cells were kindly provided by Dr. Chundong Yu (Xiamen
University, China). RBE human cholangiocarcinoma cells
and HEK293T human embryonic kidney cells were pur-
chased from the Type Culture Collection of the Chinese
Academy of Sciences (Shanghai, China). All CCA cell
lines were cultured in RPMI-1640 medium with 10 %
fetal calf serum. HEK-293 T cells were cultured in
DMEM medium with 10 % fetal calf serum. All cells
were maintained in a 37 °C humidified incubator with
5 % CO2.
qRT-PCR analysis
Cells were collected in EP tubes. Then, total RNA was
extracted from tissue or cells using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) following the manufac-
turer’s instructions. RNA was reverse-transcribed into
cDNA with the ReverTra Ace® qPCR RT Kit (TOYOBO,
Japan) or PrimeScript® RT reagent Kit with gDNA Eraser
(Takara, Japan). Real-time PCR for lncRNA was
performed using the SYBR Premix ExTaq real-time PCR
kit (Takara, Japan) according to the manufacturer’s in-
structions with GAPDH as normalization control. The
expression level for each lncRNA and mRNA was de-
termined using the 2−△△Ct method. The specificity and
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reliability of the PCR were confirmed by sequencing
the PCR product fragments. All primers are shown in
Additional file 1: Table S1.
Oxidative stress treatment in vitro
CCA cells were treated with 1 μM H2O2 for 1 h and
1 μM glucose oxidase for 24 h for short-term and long-
term oxide incubation in vitro, respectively.
Vector construction
Full-length H19-pcDNA 3.1 vectors were purchased
from Integrated Biotech Solutions (Shanghai, China).
The pcDNA 3.1 vector was used for lncRNA and mRNA
overexpression, and the psiCHECK-2 vector was used
for the luciferase target assay. Primers and oligonucleo-
tides for full-length HULC, IL-6, and CXCR4 amplifica-
tion and 3′-UTR segments of IL-6 and CXCR4
construction are listed in Additional file 1: Table S1.
Cell transfection and luciferase target assay
We plated 1.6 × 104 RBE cells or 5 × 104 HEK-293 T cells in
48-well plates. Then, 500 ng psiCHECK-2-derived reporter
vectors (Promega, Madison, WI, USA), 500 ng pcDNA3.1
vectors overexpressing lncRNAs (Invitrogen Corporation,
Carlsbad, CA, USA), and 30 nM miRNA mimics
(GenePharma, Shanghai, China) were co-transfected with
Lipofectamine® LTX (Invitrogen Corporation, Carlsbad,
CA, USA) and Lipofectamine® 3000 (Invitrogen Corpor-
ation, Carlsbad, CA, USA). Finally, 48 h after transfection,
cells were harvested for the dual luciferase reporter assay
(Promega, Madison, WI, USA). Each experiment was re-
peated at least three times.
Protein extraction, western blotting, and antibodies
As previously described, 72 h after transfection, the RBE
cells were harvested, and total protein was extracted
from the cells using RIPA lysis buffer (Beyotime Biotech-
nology, Shanghai, China) with 1× complete ULTRA
(Roche, Nutley, USA). The proteins were detected with
antibodies against CXCR4 (ab2074, Abcam, USA), IL-6
(SC-7920, Stantacruz, USA), GAPDH (Proteintech Tech-
nology, Manchester, UK), and β-tubulin (32−2600,
Invitrogen, USA). The protein levels were normalized to
GAPDH or β-tubulin.
RNA immunoprecipitation (RIP)
In the assay, the enrichment of miRNAs binding with
AGO2, a key component of the microRNA-containing
RISC complex, were used as the positive controls, and
U6 as the negative. The AGO2 (FB261-S2, Abnova,
Taiwan) monoclonal primary antibody was rip grade,
and the procedure of rip experiment was followed to the
manual of Magan rip Kit (17−700, Millipore, USA).
Scratch wound healing assay
Transfected RBE cells were cultured in 24-well plates for
24 h in standard conditions until 80−100 % confluency
was reached. Linear wound tracks were generated with
sterile, 10-μl pipettes and maintained under standard
conditions. The scratched cells were rinsed twice with
PBS to remove non-adherent cells, and fresh RPMI-1640
medium (with no fetal calf serum) was added. Photo-
graphs of the centers of the gaps were taken using a 10×
phase-contrast microscope (Zeiss). Cell migration at 0
and 24 h after scratching was evaluated by determining
the wound distance at two random wound gap locations.
Three independent scratch wound experiments were
used for calculations.
Migration and invasion assays
Migration and invasion assays were conducted using
Transwell chambers (8 μm, Corning Costar Co.,
Cambridge, USA) according to the manufacturer’s in-
structions. For the migration assays, 8 × 104 RBE cells
transfected after 24 h were plated in the top chambers
lined with a non-coated membrane. For the invasion
assay, the chamber inserts were coated with a 1:9
deliquation of Cultrex® Basement Membrane Extract
(Trevigen, USA). Then, 1.2 × 105 cells were plated in the
top chamber, while 600 μl RPMI-1640 with 10 % fetal
bovine serum was added to the lower chamber as a
chemoattractant. After a 24-h incubation at 37 °C, cells
located in the lower chamber were fixed with 100 %
methanol and stained with 0.1 % crystal violet. Cells were
counted in ten fields for triplicate membranes at 10× mag-
nification using a microscope (Zeiss). Five random sights
in each sample were selected to analyze cell count, and
the mean of triplicate experiments was calculated.
Results
H19 and HULC involved in inflammation-associated
pathways triggered by oxidative stress in CCA cell lines
In human bile duct cells, inflammatory responses were
usually triggered by oxidative stress, which was induced
by HBV, HCV, or excretory-secretory proteins released
by C. sinensis or O. riverine [6, 8]. We speculated that
the lncRNAs stimulated by oxidative stress may trigger
inflammation in CCA. To identify whether any lncRNA
related with inflammation is regulated by oxidative
stress, we firstly reanalyzed several GEO data, GSE76743
[29], GSE57539 [30], GSE67106 [31], GSE55146 [32],
and GSE70544 [33], and identified 40 lncRNAs respond-
ing to oxidative stress or inflammatory response (Fig. 1a).
Among these, XIST, CDKN2B-AS1, CRNDE, TUG1,
SOX2-OT, etc. have been reported playing crucial roles
in inflammation pathway of cancer progression. Import-
antly, two lncRNAs, HULC and H19, showed higher
expressed among all of the five selected datasets,
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suggesting that they may involve in inflammation path-
way that is regulated by oxidative stress. To validate the
expression patterns of HULC and H19 under oxidative
stress, we then used three human CCA cell lines,
QBC939, SK-cha-1, and RBE, for short-term or long-
term oxide incubation using H2O2 and glucose as
described in previous studies [34] and measured the ex-
pression levels of HULC and H19 by qPCR. The results
showed that both lncRNAs were significantly up-
regulated in three cell lines (Fig. 1b), suggesting a poten-
tial function in acute oxidative stress responses.
Similarly, HULC and H19 were also significantly up-
regulated in at least two cell lines after long-term oxida-
tive stress induced by glucose oxidase (Fig. 1c), and these
two lncRNAs might be more likely to contribute to the
pathogenesis of CCA through chronic inflammation
caused by long-term oxidative stress. It is worth noting
that HULC and H19 were up-regulated after both short-
and long-term oxidative stress, implying their pivotal
roles in inflammation promotion and CCA pathogen-
esis. Additionally, we have also investigated the heme
oxygenase-1 (HO-1) gene expression, which were re-
ported to have the cytoprotective effect under various
pathophysiological stimulating conditions, such as oxi-
dative stress [35]. As a result, the expression of HO-1
had increased significantly under the oxidative stress
condition (Additional file 1: Figure S1), suggesting
that the HO-1 may also protect cholangiocarcinoma
from oxidative stress [36, 37].
lncRNAs H19 and HULC regulate cholangiocyte migration
and invasion
Combined with previous observations, we speculated
that H19 and HULC are stimulated by oxidative stress
Fig. 1 Analysis of Inflammation-associated lncRNAs. a Heat maps of differential lncRNA profiles are based on studies upon lncRNAs responded to
hypoxic and inflammatory factor. Each of the GEO data has suggested the aberrantly lncRNA related with inflammation and/or oxidative stress.
For example, GSE76743 identified endothelial cell response to hypoxia. Others: GSE57539 (PBS_VS_IL6 treated MDA-MB-231 cells), GSE67106
(Non_ VS_ inflamed Crohn’s disease), GSE55146 (Non_ VS_ cystic fibrosis bronchial epithelium), and GSE70544 (Normoxia_vs_Hypoxia in proximal
tubular epithelial cells (PTECs)). b LncRNAs stimulated by short-term oxidative stress using H2O2 in QBC939, SK-cha-1, and RBE cells. c LncRNAs
stimulated by long-term oxidative stress using glucose oxidase in QBC939, SK-cha-1, and RBE cells
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and regulate inflammation pathways involved in CCA
pathogenesis. To validate this speculation, we investi-
gated the function of H19 and HULC in CCA cells.
Several inflammation pathways are involved in CCA by
modifying migration and invasion; therefore, we used
scratch wound healing assays to further demonstrate the
function of H19 and HULC in migration potency. After
24 h in culture, CCA cells with forced expression of H19
or HULC (Additional file 1: Figure S2A) dramatically
promoted wound closure compared to the control
(Fig. 2a), suggesting that H19 and HULC have migration
regulating roles. We also performed migration assays
and invasion assays to validate the migration and inva-
sion abilities of H19 and HULC. Consistence with the
scratch wound healing assays, H19 and HULC signifi-
cantly expedited migration (2.0-fold for H19 and 3.3-fold
for HULC, Fig. 2b) and invasion (1.77-fold for H19 and
1.64-fold for HULC, Fig. 2c), which further strengthened
the migration and invasion roles of H19 and HULC in
CCA. Furthermore, we also investigated the migration
and invasion abilities of RBE cells when knocking down
H19 or HULC. The results showed that the migration
(Additional file 1: Figure S3A) and invasion (Additional
file 1: Figure S3B) abilities of RBE cells were decreased
when H19 or HULC was knocked down (Additional file 1:
Figure S2B). These data imply that H19 and HULC may
regulate the inflammation factors regulating migration
and invasion after stimulating oxidative stress.
H19 and HULC sponge a set of miRNAs and the
inflammation factors
We further investigated the potential target genes of
H19 and HULC and the underlying regulatory mecha-
nisms. Previous studies showed that both H19 and
HULC are similar to ceRNAs [38] in human embryonic
kidney cells and human embryonal carcinoma cells by
sponging let-7 and miR-372, respectively [27, 39]. To de-
termine whether H19 and HULC have similar roles in
CCA, we focused on the potential functions of the let-7
and miR-372 families in CCA cells (Additional file 1:
Figure S4A). We used bio-informational predicting and
found the let-7 might target IL-6, one of the most import-
ant inflammatory factors in the pathogenesis, growth and
migration of CCA [40], and miR-372 and miR-373 might
target CXCR4, a chemokine receptor involved in CCA
progression and metastasis [41] (Fig. 3a). Subsequently, a
Fig. 2 Enforced H19 and HULC expression increased the ability of migration and invasion in CCA cells. a Scratch wound healing assays of CCA
cells. b Migration assays of CCA cells. c Invasion assays of CCA cells
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dual luciferase reporter system (Additional file 1: Figure
S4B) and a western bolt assay (Fig. 3b) in RBE CCA cells
had identified the direct regulation of IL-6 and CXCR4 by
let-7a/let-7b and miR-372/miR-373, respectively. We also
performed miRNA down-regulation experiment by
transfecting the miRNA inhibitors into RBE cells under
oxidative stress and found that the expression levels of
IL-6 and CXCR4 increased significantly (Fig. 3c, d,
Additional file 1: Figure S5). These results revealed that
the activation of these mRNAs over oxidative stress is
miRNA-dependent.
lncRNAs H19 and HULC function through a ceRNA pattern
in the inflammation pathway
To further confirm whether H19 and HULC regulate
inflammation and CCA pathogenesis through ceRNA
patterns, we co-transfected miRNAs, 3′-UTR, and
lncRNAs in HEK-293 T and RBE cells. Compared
with empty vectors, we found that overexpressed
lncRNAs rescued the luciferase activity suppressed by
miRNAs (Fig. 3e in RBE cells and 3f in HEK-293 T
cells), suggesting that H19 up-regulates IL-6 by sup-
pressing let-7a and let-7b, and HULC up-regulates
CXCR4 by suppressing miR-372 and miR-373. More-
over, we further performed a RNA immunoprecipita-
tion (RIP) experiment to investigate the direct
binding of H19, HULC to their certain miRNAs. In
the assay, the enrichment of miRNAs binding with
AGO2, a key component of the microRNA-containing
RISC complex, were used as the positive controls and
U6 as the negative [42]. The RIP results revealed that
H19 and HULC were associated with the AGO2
protein in CAA cells (Fig. 4a, b). Moreover, we
detected the AGO2-immunoprecipitated lncRNAs with or
without miRNAs that knocked down by inhibitors.
The results showed that the enrichment of AGO2-
immunoprecipitated H19 and HULC was decreased in the
let-7a/7b or miR-372/373 inhibitors transfected into RBE
cells (Fig. 4c), indicating that H19 and HULC are directly
binding to the certain miRNAs, let-7a/7b, miR-372/373,
and function as ceRNA manner in CAA cells. The protein
levels were also measured and overexpressed H19 or
HULC in RBE cells increased the abundance of IL-6 and
CXCR4 proteins, respectively (Fig. 4d, e). Additionally, we
further testified that both of their target genes IL-6 and
CXCR4 are down-regulated when H19 and HULC are
knocked down, respectively, in RBE cells under the oxida-
tive stress condition (Fig. 4f, g). Functional validation also
indicated that forced expression of IL-6 and CXCR4 plays
a similar role to H19 and HULC in promoting cell migra-
tion and invasion in CCA cells (Additional file 1: Figure
S6 and S7). These results suggested that H19 and HULC
regulate cell migration and invasion by increasing IL-6
and CXCR4 levels through sponging let-7a/let-7b and
miR-372/miR-373, respectively.
In conclusion, our results suggest that two inflammation-
associated lncRNAs in CCA, H19 and HULC, target
inflammatory genes, including IL-6 and CXCR4, using
ceRNA methods and primarily regulated cell migration and
invasion (Fig. 5). These lncRNAs might serve as key regula-
tors in CCA.
Discussion
The importance of several dysregulated lncRNAs has
been implicated in developmental regulation and dis-
ease pathogenesis, and the function of many dysregu-
lated lncRNAs have been reported in various cancers
[28, 43–45]. However, no studies on lncRNAs associ-
ated with CCA migration and invasion have been re-
ported. In this study, we found that H19 and HULC
targeted IL-6 and CXCR4, respectively, by sponging
miRNAs in CCA cells. The study provides new
insight into the mechanism linking lncRNA function
with CCA and may serve as novel targets for the de-
velopment of new countermeasures of CCA.
A number of studies have revealed that IL-6 was
released by autocrine and paracrine by malignant
cells or immune cells and functioned in tumorigen-
esis [40, 46, 47]. Generally, IL-6 was secreted by
noncancer stem cells in low-attachment culture
conditions and enriched Oct4 gene expression by ac-
tivating the IL-6R/JAK/STAT3 signaling pathway in
chronic inflammatory disease, such as cholangiocarci-
noma [47, 48]. Our previously study also found
treatment of CAA cells with IL-6 can active paracrine
IL-6/STAT3 pathway in inflammation and CCA
initiation [49]. IL-6 is a multifunctional inflammatory
cytokine that plays a major role in the response of
cholangiocytes to inflammation [40, 50]; and in-
creased concentrations of IL-6 during inflammation
(See figure on previous page.)
Fig. 3 H19 and HULC regulated genes via ceRNA behaviors. a Schematic representation of the interaction between miRNAs and the 3'-UTR of IL-6 or
CXCR4. b Let-7a/let-7b and miR-372/miR-373 reduced the abundance of IL-6 and CXCR4 proteins, respectively in CCA cells. The right histogram
analyzed the relative fold charges of protein levels. Triplicate experiments were analyzed by mean ± SD, p value <0.01, **, <0.05, *. MiRNA down-
regulation by transfecting the miRNA inhibitors into RBE cells under oxidative stress, and the expression levels of IL-6 (c) and CXCR4 (d) increased
significantly. Enforced expressed of H19 and HULC rescued luciferase activity for vectors with the 3'-UTR of IL-6 or CXCR4, which were suppressed by
let-7a/let-7b and miR-372/miR-373, respectively, in RBE cells (e), and in HEK-293 T cells (f)
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in the biliary tract stimulates several pathways, in-
cluding the JAK-STAT pathway, the p38 MAPK path-
way, the ERK pathway, and the PI3-kinase pathway,
and is involved in survival and growth of malignant
cholangiocytes [40, 51]. CXCR4 is a chemokine re-
ceptor involved in several inflammatory processes and
diseases, including CCA [52], and induces CCA cell
migration and invasion via the ERK 1/2 and Akt
pathways [53, 54]. However, a single lncRNA can
regulate multiple target genes, and a powerful
inflammation-related lncRNA might also target mul-
tiple inflammation genes, for example, H19 targets
TGFβ1 in prostate cancer cells [55]; TGFβ1 is a key
regulator in CCA inflammation [1], suggesting the
pivotal role of inflammation regulation by H19.
Therefore, we speculate that H19 and HULC may act
as primary regulators of other downstream inflamma-
tion genes that initiate and sustain CCA.
The growing evidences have indicated that H19
involved in both proliferation and differentiation pro-
cesses, together with epithelial to mesenchymal transition
(EMT) and also mesenchymal to epithelial transition
(MET), suggesting its contribution in tumor both initi-
ation and progression [56]. H19 has an evolutionary
conservation secondary structure, suggesting its structure-
dependent functions, which include binding to enhancer
of zeste homolog 2 (EZH2) [57], and interacting with the
methyl-CpG-binding domain protein 1 (MBD1) and
recruiting it to some of its targets that maintain the re-
pressive H3K9me3 histone marks in their loci [58]. H19
has also been recently found to interact with P53 pro-
teins, and led to its inactivation, indicating that H19
(See figure on previous page.)
Fig. 4 The mechanism of H19 and HULC that regulated genes. a AGO2 rip-qPCR of miRNAs and lncRNAs in RBE cells. The enrichment of miRNAs binding
with AGO2 were used as the positive controls and U6 as the negative. b AGO2 rip-qPCR of miRNAs and lncRNAs in QBC939 cells. Triplicate experiments
were analyzed by mean ± SD, p value <0.001, ***. c Relative enrichment of H19 (green) and HULC (blue) were analyzed in AGO2 rip-qPCR with let-7a, let-7b
inhibitor or miR-372, miR-373 that compared to inhibitor NC. Enforced expression of different concentration of H19 (d) and HULC (e) plasmid increased IL-
6 and CXCR4 protein levels, respectively, in RBE cells. The expression of IL-6 (f) and CXCR4 (g) had decreased significantly when we knocked down H19
and HULC, respectively, under the oxidative stress condition. The right histogram of gray density to quantitatively analyze the relative fold charges of
protein levels. Triplicate experiments were analyzed by mean ± SD, p value < 0.001, ***, <0.01, **, <0.05, *
Fig. 5 Schematic representations of pathways modulated by H19 and HULC in CCA cells. H19 and HULC are up-regulated by oxidative stress
induced by viruses or liver flukes and sponging miRNAs, such as let-7a/let-7b and miR-372/miR-373. This increases the expression of
inflammation-related genes, including IL-6 and CXCR4, resulting in abnormal inflammation responses and pathogenesis of CCA
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plays a role in tumorigenesis [59]. HULC was reported
to promote the proliferation and regulated cell cycle of
HCC through down-regulation of the tumor suppressor
gene CDKN2C (p18) and involved in signaling path-
ways including ATM/ATR and p53 [60, 61]. In this
study, we revealed the potential pathway of H19 that is
targeted by let-7a/let-7b, causing the partial inactivation
of IL-6 in its mediated inflammatory responses
triggered by oxidative stress in cholangiocarcinoma. We
also found that HULC was targeted by miR-372 and
miR-373 and further activated the chemokine receptor
CXCR4 in the progression of migration and invasion
in cholangiocarcinoma cells. The results suggest a
potential pathway of lncRNAs participated in the
progression of CCA.
Previous studies indicated that oxidative stress from
infection with parasites, bacteria and viruses is highly re-
lated to the inflammatory and malignant processes of
cholangiocytes [7, 62, 63], and cholangiocytes under oxi-
dative stress might induce and augment inflammatory
responses [7, 62]. An increasing number of studies have
realized that inflammation is one of important responses
to the oxidative stress in many diseases, such as the gut
[64], lung [65], pancreatitis [66], colorectal cancer [49],
and cholangiocarcinoma [67]. Fernanda et al. also
reviewed a total of 1332 studies initially identified that
TNF-a, IL-8, IL-6, IL-1b, and NF-κB were the main in-
flammatory mediators and oxidative stress markers [65],
suggesting that the oxidative stress made a great contri-
bution in inflammatory in the initiation or progression
of disease. However, the molecular details between oxi-
dative stress and inflammation are not well defined in
CCA cells. Several previous studies have indicated that
infections are induced by oxidative stress via chronic in-
flammation [5, 7]. In this study, we found that H19 and
HULC are stimulated by both short-term and long-term
oxidative stress and regulate the expression of pivotal
genes in the inflammatory process, suggesting that there
is a positive feedback loop between inflammation and
oxidative stress, and the activation of this feedback loop
with lncRNAs might promote tumorigenesis in CCA.
Conclusions
Our study revealed that H19 and HULC were up-
regulated by oxidative stress and target IL-6 and CXCR4
via ceRNA patterns of sponging let-7a/let-7b and miR-
372/miR-373, respectively. Furthermore, overexpressed
H19 and HULC might promote cell migration and inva-
sion, suggesting that these lncRNAs might be the chief
culprits of CCA pathogenesis and progression (Fig. 5).
Our results provide new insight into the mechanism
linking lncRNA function with CCA and may serve as
novel targets for the development of new countermea-
sures of CCA.
Additional file
Additional file 1: Figure S1. The expression of heme oxygenase-1 (HO-
1) had increased significantly under the oxidative stress condition. HO-1
stimulated by short-term oxidative stress using H2O2 (A) and long-term
oxidative stress using glucose oxidase (B) in QBC939, SK-cha-1, and RBE
cells. Figure S2. qPCR validations of forced expressed H19 and HULC in
CCA cells (A) and knockdown of lncRNAs, H19, and HULC in RBE cells by
SiRNAs. Figure S3. Knockdown of H19 and HULC expression decreased
the ability of migration and invasion in CCA cells. Migration assays of
CCA cells (A). Invasion assays of CCA cells (B). Figure S4. MiRNAs targeted
inflammation-associated genes, IL-6 and CXCR4. A. Schematic representation
of the interaction between miRNAs and H19 or HULC (A). Let-7a/let-7b and
miR-372/miR-373 suppressed luciferase activity of vectors with 3'-UTR of IL-6
and CXCR4 in RBE cells (B). Figure S5. The histogram of miRNA
down-regulation by transfecting the miRNA inhibitors into RBE cells
under oxidative stress. The expression levels of IL-6 (A) and CXCR4
(B) increased significantly. Figure S6. Western Blot validations of
forced expressed IL-6 and CXCR4 in CCA cells. CXCR4-1 and CXCR4-2
represent two alternative splicing of CXCR4. The right histogram of
relative gray values represented the protein level. Figure S7. Enforced IL-6
and CXCR4 expression increased the ability of invasion in CCA cells. Scratch
wound healing assays of CCA cells (A). Migration assays of CCA cells (B).
Invasion assays of CCA cells (C). Table S1. Primer sequence for qPCR and
vector construction. (PDF 1109 kb)
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